Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

432

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2010

Conditions
Pulmonary Fibrosis
Interventions
DRUG

low dose BIBF1120 once daily

low dose BIBF1120 once daily

DRUG

low dose BIBF 1120 twice daily

low dose BIBF 1120 twice daily

DRUG

intermediate dose BIBF 1120 twice daily

intermediate dose BIBF 1120 twice daily

DRUG

high dose BIBF 1120 twice daily

high dose BIBF 1120 twice daily

DRUG

placebo

placebo

Trial Locations (92)

Unknown

1199.30.54002 Boehringer Ingelheim Investigational Site, Mendoza

1199.30.61005 Boehringer Ingelheim Investigational Site, South Brisbane

1199.30.61003 Boehringer Ingelheim Investigational Site, Toorak Gardens

1199.30.61004 Boehringer Ingelheim Investigational Site, Woodville

1199.30.61001 Royal Perth Hospital, Perth

1199.30.32004 Boehringer Ingelheim Investigational Site, Brussels

1199.30.32001 Boehringer Ingelheim Investigational Site, Leuven

1199.30.32002 Boehringer Ingelheim Investigational Site, Yvoir

1199.30.55002 Boehringer Ingelheim Investigational Site, Porto Alegre

1199.30.55001 Boehringer Ingelheim Investigational Site, Vila Clementino

1199.30.06004 Boehringer Ingelheim Investigational Site, Sofia

1199.30.06005 Boehringer Ingelheim Investigational Site, Sofia

1199.30.01003 Division of Respirology, Halifax

1199.30.01002 St. Joseph's Healthcare, Hamilton

1199.30.56001 Boehringer Ingelheim Investigational Site, Providencia

1199.30.86001 Boehringer Ingelheim Investigational Site, Beijing

1199.30.86002 Boehringer Ingelheim Investigational Site, Beijing

1199.30.86005 Boehringer Ingelheim Investigational Site, Nanjing

1199.30.86003 Boehringer Ingelheim Investigational Site, Shanghai

1199.30.86004 Boehringer Ingelheim Investigational Site, Shenyang

1199.30.42002 Boehringer Ingelheim Investigational Site, Prague

1199.30.42001 Boehringer Ingelheim Investigational Site, Ústí nad Labem

1199.30.3302A Boehringer Ingelheim Investigational Site, Bobigny

1199.30.3306A Boehringer Ingelheim Investigational Site, Dijon

1199.30.3303A Boehringer Ingelheim Investigational Site, Grenoble

1199.30.3305A Boehringer Ingelheim Investigational Site, Lille

1199.30.3305B Boehringer Ingelheim Investigational Site, Lille

1199.30.3305C Boehringer Ingelheim Investigational Site, Lille

1199.30.3304C Boehringer Ingelheim Investigational Site, Montpellier

1199.30.3307A Boehringer Ingelheim Investigational Site, Nice

1199.30.3301A Boehringer Ingelheim Investigational Site, Paris

1199.30.49008 Boehringer Ingelheim Investigational Site, Bad Berka

1199.30.49007 Boehringer Ingelheim Investigational Site, Berlin

1199.30.49006 Boehringer Ingelheim Investigational Site, Donaustauf

1199.30.49001 Boehringer Ingelheim Investigational Site, Essen

1199.30.49002 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau

1199.30.49003 Boehringer Ingelheim Investigational Site, Großhansdorf

1199.30.49009 Boehringer Ingelheim Investigational Site, Leipzig

1199.30.49004 Boehringer Ingelheim Investigational Site, Mainz

1199.30.49005 Boehringer Ingelheim Investigational Site, München

1199.30.30004 Boehringer Ingelheim Investigational Site, Alexandroupoli

1199.30.30001 Boehringer Ingelheim Investigational Site, Heraklion

1199.30.30002 Boehringer Ingelheim Investigational Site, Larissa

1199.30.36002 Boehringer Ingelheim Investigational Site, Budapest

1199.30.36003 Boehringer Ingelheim Investigational Site, Budapest

1199.30.36004 Boehringer Ingelheim Investigational Site, Deszk

1199.30.36001 Boehringer Ingelheim Investigational Site, Pécs

1199.30.36005 Boehringer Ingelheim Investigational Site, Székesfehérvár

1199.30.35301 Mater Misericordiae Hospital, Dublin

1199.30.39008 Boehringer Ingelheim Investigational Site, Ascoli Piceno

1199.30.39013 Boehringer Ingelheim Investigational Site, Busto Arsizio (va)

1199.30.39007 Boehringer Ingelheim Investigational Site, Milan

1199.30.39001 Boehringer Ingelheim Investigational Site, Modena

1199.30.39012 Boehringer Ingelheim Investigational Site, Napoli

1199.30.39009 Boehringer Ingelheim Investigational Site, Pavia

1199.30.39011 Boehringer Ingelheim Investigational Site, Roma

1199.30.39010 Boehringer Ingelheim Investigational Site, Siena

1199.30.39003 Boehringer Ingelheim Investigational Site, Terni

1199.30.39004 Boehringer Ingelheim Investigational Site, Trieste

1199.30.52001 Boehringer Ingelheim Investigational Site, Distrito Federal

1199.30.31002 Boehringer Ingelheim Investigational Site, Nieuwegein

1199.30.35105 Boehringer Ingelheim Investigational Site, Coimbra

1199.30.35106 Boehringer Ingelheim Investigational Site, Coimbra

1199.30.35107 Boehringer Ingelheim Investigational Site, Lisbon

1199.30.35108 Boehringer Ingelheim Investigational Site, Lisbon

1199.30.35109 Boehringer Ingelheim Investigational Site, Lisbon

1199.30.35101 Boehringer Ingelheim Investigational Site, Porto

1199.30.07001 Boehringer Ingelheim Investigational Site, Moscow

1199.30.07002 Boehringer Ingelheim Investigational Site, Moscow

1199.30.07003 Boehringer Ingelheim Investigational Site, Saint Petersburg

1199.30.27001 Boehringer Ingelheim Investigational Site, Bellville

1199.30.27003 Boehringer Ingelheim Investigational Site, Cape Town

1199.30.27002 Boehringer Ingelheim Investigational Site, Tygerberg

1199.30.82002 Boehringer Ingelheim Investigational Site, Gyunggido

1199.30.82004 Boehringer Ingelheim Investigational Site, Incheon

1199.30.82001 Boehringer Ingelheim Investigational Site, Seoul

1199.30.82003 Boehringer Ingelheim Investigational Site, Seoul

1199.30.82005 Boehringer Ingelheim Investigational Site, Seoul

1199.30.34001 Boehringer Ingelheim Investigational Site, Barcelona

1199.30.34002 Boehringer Ingelheim Investigational Site, Valencia

1199.30.88605 Boehringer Ingelheim Investigational Site, Taichung

1199.30.88601 National Taiwan University, Taipei

1199.30.88603 Tri-service General Hospital, Taipei

1199.30.88606 Boehringer Ingelheim Investigational Site, Taipei

1199.30.88604 Chang Gung Memorial Hosp-Linkou, Taoyuan District

1199.30.90001 Boehringer Ingelheim Investigational Site, Ankara

1199.30.90002 Boehringer Ingelheim Investigational Site, Istanbul

1199.30.44006 Boehringer Ingelheim Investigational Site, Aberdeen

1199.30.44003 Boehringer Ingelheim Investigational Site, Birmingham

1199.30.44005 Boehringer Ingelheim Investigational Site, Birmingham

1199.30.44007 Boehringer Ingelheim Investigational Site, Manchester

1199.30.44001 Boehringer Ingelheim Investigational Site, Westbury on Trym

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00514683 - Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter